ARTICLE | Company News
Vivus withdraws Alibra NDA
October 20, 2000 7:00 AM UTC
VVUS withdrew its NDA for Alibra, a urethral microsuppository of alprostadil and prazosin to treat erectile dysfunction (ED). The company said that it will meet with the FDA to determine what addition...